SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-050551
Filing Date
2022-04-26
Accepted
2022-04-26 21:34:11
Documents
2
Period of Report
2022-04-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2212815-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2212815-4_4seq1.xml 4 5663
2 EXHIBIT 24 tm2212815d4_ex24.htm EX-24 5930
  Complete submission text file 0001104659-22-050551.txt   13233
Mailing Address C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100 MILPITAS CA 95035
Business Address
PATEL DINESH V PH D (Reporting) CIK: 0001120477 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 22856061

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations